Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 4, 2012
The origin of stroma surrounding epithelial ovarian cancer cellsTomoko Akahane, Akira Hirasawa, Hiroshi Tsuda, et al.
Oncology Reports|January 8, 2013
New candidate therapeutic agents for endometrial cancer: potential for clinical practice (review)Kiyoko Umene, Kouji Banno, Iori Kisu, et al.
Anticancer Research|April 13, 2016
Retrospective Analysis on the Feasibility and Efficacy of Docetaxel-Cisplatin Therapy for Recurrent Endometrial CancerTomomi Ninomiya, Wataru Yamagami, Nobuyuki Susumu, et al.
Journal of Human Genetics|October 4, 2013
Polymorphisms in the UGT1A1 gene predict adverse effects of irinotecan in the treatment of gynecologic cancer in Japanese patientsAkira Hirasawa, Takeru Zama, Tomoko Akahane, et al.
Gynecologic Oncology|January 28, 2020
Clinical status and prognostic factors in Japanese patients with uterine leiomyosarcomaKazuhiro Takehara, Natsumi Yamashita, Reiko Watanabe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 1, 2017
A Comparison of Dye Versus Fluorescence Methods for Sentinel Lymph Node Mapping in Endometrial CancerWataru Yamagami, Nobuyuki Susumu, Fumio Kataoka, et al.
Gynecologic Oncology|October 20, 2004
HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cellsNao Suzuki, Daisuke Aoki, Yutaka Tamada, et al.
Genes, Chromosomes & Cancer|May 13, 2014
Simultaneous analysis of the gene expression profiles of cancer and stromal cells in endometrial cancerYoko Iguchi, Yoichi M Ito, Fumio Kataoka, et al.
Japanese Journal of Clinical Oncology|March 24, 2017
Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancerKenta Masuda, Akira Hirasawa, Haruko Irie-Kunitomi, et al.
Pageof 13